NantHealth open to reveal clinical operating system to the NHS Annual Conference and Exhibition Confederation -
NantHealth, a health care company transformational converging science and technology through a single integrated clinical platform, will unveil the first open clinical operating system of industry (CoS) for value-based, coordinated care to the NHS Confederation annual Conference and exhibition this year. CoS is an intelligent cloud platform integrates, financial, clinical and operational environmental data that is empowering clinicians, providers, patients, commissioners, social care workers and researchers to transcend traditional barriers System health care today and allow health and social services integration to be truly realized.
"mission NantHealth is to solve the major problems affecting our health system, which is the lack of truly personalized care models, coordinated and proactive linking patients and their caregivers "said Dr. Patrick Soon-Shiong, MD, founder and pioneer NantHealth pharmaceutical treatments for diabetes and cancer. "Our most important industry, health care is fragmented and accuses every other industry in its ability to integrate services quickly and introduce new practices. CoS is the first viable platform, proven to make complex information such as genomic profile of someone as simple as their heart rate and blood pressure. Our ability to design, automate and offer new models and systems of care is essential to advance 21 st century medicine, and for the first time, is now possible. "
A, standards-based technology platform open CoS integrates data from existing systems, such as electronic patient records (EPR), patient administration systems (PAS) from multiple platforms, imaging, GP systems, diagnosis, research, data from medical devices, patient level costs and reporting services online, in real time, to allow care that is personalized, coordinated and proactive. When CoS capacity combined with NantHealth applications such as molecular diagnosis of advanced and care coordination applications, decisions can be made in seconds, and patients matched to appropriate treatment protocols - ultimately saving lives and reduce costs of delivery. Health care and care becomes transformative for carers and the people they serve.
NantHealth CoS is the centerpiece of an investment of $ 1 billion by Dr. Soon-Shiong, which brought together some of the most innovative companies and solutions in biotechnology and health IT in order to provide the right care, at the right time, right place and at the lowest cost. He has pioneered treatments for diabetes and cancer, published over 100 scientific papers and holds over 95 patents on the revolutionary progress across multiple fields. Dr. Soon-Shiong performed first encapsulated human islet transplantation in the world and the first pig to man islet cell transplant in diabetic patients and invented and developed Abraxane, the first US government approved injectable drug use nanoparticle human protein technology transfer in breast cancer treatment, lung cancer and pancreatic cancer. Dr. Soon-Shiong is the founder of two multi-billion dollar pharmaceutical companies.
NantHealth CoS is exposed and the full range of health transformation solutions to the NHS Confederation Annual Conference and Exhibition NantHealth, 4-7 June, at ACC Liverpool.
EmoticonEmoticon